Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Livzon Pharmaceutical Group ( (HK:1513) ) has provided an update.
Livzon Pharmaceutical Group Inc. has announced the completion of the cancellation of share options under its 2022 Share Options Incentive Scheme. This move, verified by the Shenzhen Branch of China Securities Depository and Clearing Co., Ltd., indicates a strategic adjustment in the company’s incentive structure, potentially impacting its financial strategy and shareholder relations.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and sale of a wide range of pharmaceutical products. The company is known for its commitment to innovation and quality in the healthcare sector.
YTD Price Performance: -2.90%
Technical Sentiment Signal: Sell
Current Market Cap: $3.9B
See more insights into 1513 stock on TipRanks’ Stock Analysis page.